chrisvoncsefalvay/vaers-outcomes huggingface dataset:
DID NOT FEEL FABULOUS; This spontaneous report received from a patient via a social media via company representative concerned a patient of an unspecified age, sex, race and ethnicity. The patient's weight, height, and medical history were not reported. The patient had previously received covid-19 vaccine ad26.cov2.s (unspecified manufacturer) (dose number in series 1) (suspension for injection, route of admin and batch number were not reported, and expiry: Unknown) dose was not reported, 1 total, dose 1 was administered on an unspecified date for covid-19 prophylaxis. It was unknown whether patient had any adverse events following vaccination with covid-19 vaccine ad26.cov2.s (unspecified manufacturer) (dose number in series 1). The patient received covid-19 vaccine ad26.cov2.s (unspecified manufacturer) (dose number in series 2) (suspension for injection, route of admin and batch number were not reported, and expiry: Unknown) dose was not reported, 1 total, dose 2 (booster) was administered on an unspecified date for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date following vaccination with booster dose of covid-19 vaccine ad26.cov2.s, the patient did not feel fabulous (Adverse event NOS) (dose number in series 2). It was reported as, "I didn't feel fabulous after my Omicron booster, but it's a small price to pay to stay safe. I wear a mask at the grocery store. My son died from the after effects of Covid. It's a long story". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of did not feel fabulous was not reported. This report was non-serious. This case, from the same reporter is linked to 20221244119.
Pt came into the store and stated that they needed the second shot of his series. When asked, he stated that he received the J&J. We told him that the J&J was a one shot series, he then said that it must have been the moderna then. We administered the Moderna to him. After he left, I checked system and found out that his first shot was Pfizer and not Moderna.
Left deltoid / biceps ; erythema, hot, painful and indurated 3" x 4" .
Constant ringing of the ears; This is a spontaneous report from a contactable other healthcare professional, the patient. A 58-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Er8730) via an unspecified route of administration in the left arm on 28Mar2021 at 09:45 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and hyperthyroidism. The patient had a history of allergy to sulfur. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN), venlafaxine (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN) and lansoprazole (MANUFACTURER UNKNOWN); all from unknown date for unknown indication. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 28Mar2021 at 19:00, the patient experienced constant ringing of the ears. The patient did not receive any treatment for the reported event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event constant ringing of the ears was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Site: Pain at Injection Site-Medium, Systemic: Generalized Body Aches -Severe, Systemic: Headache-Severe, Systemic: Severe drop in blood pressure, pulse, and o-sat-Severe
Pt. experienced dizziness, palpitations, disorientation upon administration of HPV vaccine (about 2 minutes post injection - while pt. was waiting in waiting room). Called fire dept. and pt. was escorted to hospital.
This is an instance of breakthrough COVID-19 disease after which death occurred. The individual was vaccinated with the Pfizer product on 01/04/2021, 01/25/2021, 11/30/2021, and 05/05/2022. They tested positive for COVID-19 on 07/25/2022 at the nursing home at which they were a resident. I see no indication they were hospitalized for this illness. They  experienced a cardiopulmonary arrest and died on 07/29/2022.
4 hours after vaccination patients arm started swelling and pain radiated down arm from injection site. Arm swelled, was red to the touch and hard from the deltoid muscle all the way to the inner elbow. Vaccinated on 6/22/18 and symptoms subsided on 6/26/18 with arm elevation, alternating hot and cold compress and taking Naproxen PRN.
Fever, chills, body aches, fatigue, fainting through first night. Body aches and fatigue next day and night. Still have some aching and fatigue on fri, second full day after vaccination
Localized swelling, sore throat, fatigue, PVC's.  Was seen in ER on 10/30/2019 for frequent PVC's, Followed up with the Cardiologist , had a heart echo cardiogram and wearing a 30 day heart monitor.
Initial report was received 22 March 2012 from a consumer. A child (age and date of birth not reported) had received PENTACEL (lot number, dose number, route, site and date of administration not reported) and an unspecified amount of time later, experienced pallor, breathing difficulty and bradycardia. The patient received treatment and was "ok" (also reported as recovered). The reporter was informed of this event from a health care provider who stated that the child was a patient at someone else's practice. The reporter declined to provide contact information and stated they had no further information to provide. Documents held by sender: None.
Cough/mucous production that is greenish; did not feel good; Headache; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Cough/mucous production that is greenish), MALAISE (did not feel good) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COUGH (Cough/mucous production that is greenish), MALAISE (did not feel good) and HEADACHE (Headache). At the time of the report, COUGH (Cough/mucous production that is greenish), MALAISE (did not feel good) and HEADACHE (Headache) had not resolved.            No information on concomitant medication were reported. No treatment details were reported. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.   Most recent FOLLOW-UP information incorporated above includes: On 19-Aug-2021: significant  Live Follow up appended. Narrative added.
In the days following my first dose of the Pfizer vaccine, I had nerve pain in both of my hands when I bent my wrists forward. This pain continued in my left hand for a couple months, although my left hand now feels fine. My right hand continues to have nerve pain though when I extend my arm and bend my wrist forward even slightly. This has prevented me from doing certain activities that I'm accustomed to doing. The pain in my right hand is still as severe as it was when it initially started in April.
chills; fever; body aches.; The arm that received the vaccination was sore and itchy; The arm that received the vaccination was sore and itchy; Flu like symptoms after booster; Aches; Slight fever; Tired; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the patient.  An elderly female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administration date 29Sep2021 (Lot number: fe-3592) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot #: EN6200), administration date: 16Feb2021, for Covid-19 immunization; Bnt162b2 (DOSE 2, SINGLE, Lot #: EN6199), administration date: 10Mar2021, for Covid-19 immunization, reaction(s): "Tired"; Bnt162b2 (DOSE 2, SINGLE, Lot #: EN6199), for Covid-19 immunization, reaction(s): "Slight fever". The following information was reported: CHILLS (non-serious) with onset 30Sep2021, outcome "recovered", described as "chills"; PYREXIA (non-serious) with onset 30Sep2021, outcome "recovered", described as "fever"; PAIN (non-serious) with onset 30Sep2021, outcome "recovered", described as "body aches."; VACCINATION SITE PAIN (non-serious), VACCINATION SITE PRURITUS (non-serious) all with onset 30Sep2021, outcome "recovered" and all described as "The arm that received the vaccination was sore and itchy"; INFLUENZA LIKE ILLNESS (non-serious) with onset Sep2021, outcome "recovered", described as "Flu like symptoms after booster"; PAIN (non-serious) with onset Sep2021, outcome "recovered", described as "Aches"; PYREXIA (non-serious) with onset Sep2021, outcome "recovered", described as "Slight fever"; FATIGUE (non-serious) with onset Sep2021, outcome "recovered", described as "Tired". Relevant laboratory tests and procedures are available in the appropriate section. It was unknown if therapeutic measures were taken as a result of chills, pyrexia, pain, vaccination site pain, vaccination site pruritus.  Additional information: Vaccine facility type was Pharmacy or drug store. It was unknown if other vaccines was received in four weeks. It was unknown if other medications was received in two weeks. It was unknown if patient was diagnosed with covid prior vaccination. It was unknown if patient was tested for covid post vaccination. Booster dose was taken due to high risk of frequent institutional or occupational exposure to coronavirus (and at risk of serious COVID-19 complications) (Over 65 age).  Follow-up attempts are completed. No further information is expected.
He initially presented to Hospital densely encephalopathic minimally responsive requiring hemodialysis. He made gradual recovery in renal function and was able to be liberated from hemodialysis approximately 2 weeks after his transfer his dialysis catheter was removed his mental status slowly improved and he was allowed to begin oral diet although with limited desire to eat. He remained confused but became more interactive conversant and more participatory in his care. He did have persistent diarrhea and a been found to have C. difficile positive stools prior to transfer felt this represented relapse infection and he was treated with a course of oral vancomycin for 10 days. His diarrhea had resolved he was progressing towards discharge. His physical exam had remained stable vital signs were unremarkable on the night of his death telemetry alerted to the presence of bradycardia followed by asystole CODE BLUE was called he was found unresponsive ACLS was provided but despite multiple rounds of CPR he could not be resuscitated.
Just want to report the "Severe Muscle Pain" reaction to my pneumonia vaccine from yesterday. OUCH! Serious pain. It will go away though. I'll be fine. Just wanted to report it.
Red hard painful welt at injection site that was extremely sensitive to the touch. Took two weeks for discoloration to go away and finally peeled. Started night of vaccination and got worse the second day. Started to get less painful third day and better each day after
The second day, I started experiencing consistent elevated heart rates with an average of 112.  This lasted for the better part of the day but by the next day, I was only experiencing 'episodes' of elevated HR.
Day 2 (Saturday)- Dizziness & severe nausea beginning early AM.  Other symptoms include arm pain, joint pain, severe headache, pronounced fatigue. Symptoms persisted 3-4 days. ZOFRAN ordered by PCP on day 2 due to vomiting with 1st shot. 3 doses zofran taken total, day 2 & 3. Tylenol taken for headache, & joint pain x 2 doses on day 2. All symptoms resolved by day 4 except for occasional dizziness. "Patient states does not take medicine well.  Patient states symptoms started sooner and were worse than 1st shot." Day 4-6 arm itchy.
Pt recv vax on 11/17/98; 15 min post vax pt exp red blotches/ rash at back of neck, throat, arms, chest then covering entire body
Right upper extremity numbness/weakness onset 48 hours after J&J Covid booster.  Had received initial J&J vaccination prior.  Brain MRI showed cerebral infarctions in LEFT middle cerebral artery (MCA) distribution.  No prior history of HTN, hyperlipidemia.  Non-smoker.  As of today, 12/29/21, symptoms have IMPROVED but not completely resolved.
This spontaneous report was received from a pharmacist refers to a patient of unknown age and gender. on 05-SEP-2014 the patient was vaccinated with RECOMBIVAX HB, (dose 1, route-unspecified) followed by the second dose on 06-OCT-2014. It was reported that the patient had not received the third dose yet but was planning to get it on 30-OCT-2015 (inappropriate schedule of drug administration). No adverse effects were reported. No product quality complaint (PQC) was involved. The outcome of the events is unknown. The reporter considered the events to be not related to RECOMBIVAX HB. Additional information has been requested.
Joint pain rt foot,rt knee,rt wrist & sometimes rt elbow and lft wrist. Headaches are more frequent than normal. Having problems with sleep.
Pain and tender to the touch in right upper deltoid where Adacel was administered for several weeks after administration. Patient reported the symptoms to our pharmacy on 2/27/13 after receiving 4 vaccines (Havrix  R lower delt; Engerix B  L lower delt; Ixiaro  L upper delt) on 1/28/13. She had minor pain at injection sites from the other 3 vaccines that resolved after 3-4 days. The pain at the site of Adacel vaccine continues with pain of 3/10 and max of 5/10 when she uses her arm. Pain is worsened when lifts arm to drive, uses arm, or lifts weights. The patient does report that she has been lifting weights daily starting the day of vaccination. She currently has no pain in left arm.
shingles, nasociliary branch. started with burning in the inside of my left Nare, vesicular rash appeared which spread to the tip of my nose.  I immediately (day 2 of rash) started valtrex 1gm TID.  After 48 hours on valtrex no progression of rash.  I have not had any visual symptoms (herpes opthalmicus) yet and hopefully don't.
This spontaneous report was received from a licensed practical nurse and refers to a patient of unknown age and gender. The patient's medical history, drug reactions or allergies and concurrent conditions were not reported. On 29-OCT-2015, the patient was vaccinated with a dose of improperly stored (Oka/Merck) VARIVAX (route, anatomical location were not reported), lot number J013900, expiration date 30-OCT-2015. No adverse effects were reported. There was no concomitant medication reported. Additional informatiton has been requested.
3 days after vaccine, high fever and febrile seizure, V/P, VAQATA, HepA #2
had an anaphylactic reaction; Seriousness criteria: Other- Important medical event- anaphylactic reaction.  Initial information received on 28-Jun-2019 regarding an unsolicited valid serious case received from a pharmacist.  This case involves an unknown age female patient who experienced an anaphylactic reaction, while she received vaccine INFLUENZA QUADRIVAL A-B INTRADERMAL VACCINE [FLUZONE INTRADERMAL].  The patients past medical history, concomitant medication and family history were not provided.  At the time of the event, the patient had ongoing allergic to Agar.  Notes: Patient does not have an allergy to gelatin or eggs  On an unknown date, the patient received a dose of injection of suspect INFLUENZA QUADRIVAL A-B INTRADERMAL VACCINE (the 2012 to 2013 formulation) lot number, expiry date not reported via unknown route in unknown administration site.  On an unknown date, the patient developed a serious had an anaphylactic reaction (anaphylactic reaction) with unknown latency following the administration of INFLUENZA QUADRIVAL A-B INTRADERMAL VACCINE. This event was assessed as medically significant.  Relevant laboratory test results included: On an unknown date: [allergist tested with saline and 1:100, 1:10 ratio of the Fluzone Intradermal and patient reacted to the 1:100 ratio]  Final diagnosis was had an anaphylactic reaction.    It was not reported if the patient received a corrective treatment.  The patient outcome is reported as Unknown for had an anaphylactic reaction.  List of documents held by sender: None. Information on batch number was requested for this case.; Sender's Comments: This case concerns an adult patient who developed anaphylactic reaction after vaccination with FLUZONE INTRADERMAL. The patient is allergic to Agar. The time to onset is unknown. Moreover, there is no information regarding patient's past history, medical condition at time of vaccination and lab tests ruling out alternate etiologies, Based upon information reported, the role of the vaccine cannot be assessed in this case.
Pt developed shingles just over 2 months after her second coronavirus vaccine. This is the third case of shingles that I've seen in a young adult female after the Pfizer vaccine.
-full body rash slightly raised appearing within about 3 hours of vaccination. Treatment was BENADRYL (diphenhydramine)
Contracted nurse on-site inserted 0.3 ml Pfizer vaccine into patient. She then with drew syringe without injecting. She then re inserted the needle again and administered the vaccine. According to the nurse, she had a lapse in judgement and gave it appropriately the second time. However, she did not change needles and also didn't put the syringe directly in the sharps container after use. Patient is concerned that she was given no vaccine, 2 doses, or 1 syringe of air and a second of vaccine. According to the nurse, she did give 1 dose of the medication but lied at the time at what was going on.
Chronic nonstop dizziness, burning head, brain fog, inability to walk any distance without feeling of drugged drunkenness. Off-balance. Onset three weeks after second vaccine, has been steady 24/7 since then.
Approximately 20 minutes after vaccination (9:25 AM), child was in lobby with parent and it was reported that child had tonic movements, pale and blue around mouth, eyes rolling back, stiff body for about 20 seconds. Oxygen was given and child regained color instantaneously. Blood pressure was 92/64 with pulse at 64. Oxygen saturation quickly following oxygen administration was 99-100%. Child was awake, alert and stable. At 9:38 AM child was taken to hospital via ambulance for further evaluation.
Patient states that following the flu shot, he has had continued pain in his shoulder above where the flu shot was given. It required MD visit and physical therapy.
Mild fever of about 100; body aches; flu like symptoms; cough lasted for 6 weeks; joint aches; mental fog.
Fever, grand mal seizures and was started on dilantin during hospitalization. Dr's nurse reports that he diagnosed the child with febrile seizure and urinary tract infection. He did not recommend any changes in future immunization scheduling for the patient. Patient has experienced additional seizures since this hospitalization. She did not experience seizures prior to the seizures one day after the repoorted immunizations.
1 week after the vaccination Patient started with right hand pain,  Pt has burning and fire sensation that awakens at night, and he currently has the symptoms for about 2 weeks.
6/13/06, Pt caregiver brings client in for recheck and c/o last visit for immunizations ran 104 and up fever, inconsolable crying and screaming. Provider feels this is pertussis reaction.
Macular, papular skin lesion at abdomen and lower limbs, itch; erythema and fever.
25NOV96 pt devel high fever of 104 to 106 & began turning blue several times a day;became dehydrated almost & hosp;while in hosp pt exp a dec fever of 93.4;hosp x 6 days;pt pupils constrict under light, then dilate & constrict;cyanosis
REceived Moderna COVID19 vaccine on 03/17/21, 04/14/21, and 11/23/21. Presented to ER 12/30/21 and admitted. COVID positive 12/30/21. In the ED, the patient tested positive for COVID-19.  Chest x-ray was  consistent with COVID-19 pneumonia.  She had remarkable lab significant for  hyponatremia with sodium of 126, hyperkalemia with potassium of 7.2, BUN was  77, creatinine 7.6.  The patient noted to have an anion gap which was elevated  25.2, but low bicarb of 15, blood glucose elevated at 603.  BNP was 1820.   Hemoglobin 9.  Nephrologist was consulted from the ED and patient is going to  have stat hemodialysis.  Patient was also given insulin 10 units, calcium  gluconate 3 g in the ED. Patient was able to finish all treatments for COVID including: rocephin, azithromycin, remdesivir, and a full 10 day course of decadron. Discharged on 1/13/22
Seen in office 6-3-04 1 week history of cough, clear nasal discharge, red bumps on face. Temp 102 degrees 2 days previous. In office had non itchy 3-4 mm papules on arm, hand, face, one was crusted (approximately 15 lesions total). Signs prescription was advised with 5 day isolation. Seen again in office 6-5-4 lesion spread had temp cough diagnosis OM put on Amox for 10 days. Spoke with MD 6-8-04 still with some lesions.
Patient described as hives. Her elbows are swollen and her left knee is swollen and she is itchy all over her body especially on her arms and legs. The rash started at the injection site the same evening. The rest of the affected area(s) started the following  day on 10/30/2019. She started taking Benadryl (banophen) with no complete resolution. She purchased a new box 11/01/2019 b/c she discovered she may have taken expired diphenhydramine. She takes Allegra daily.
Fully vaccinated with booster on 11/22/21.   COVID infection breakthrough and inpatient hospital admit.   Receiving chemo.
Initial report received on 04 December 2009 from a health care professional. A 78-year-old female patient had received an intramuscular injection of FLUZONE SV 2009-2010 (lot number U3227A) on 05 October 2009. The patient's medical history and use of other medications were unknown. It was also unknown whether the patient had received any other vaccinations the same day she received the FLUZONE vaccine. Four days after receiving FLUZONE, the patient complained of severe pain in the neck and upper chest. She was evaluated by a physician and cardiac workup was negative. The patient was then referred to a neurologist; however result of the referral was not provided. Per the reporter, additional information will be provided in follow-up as the patient's chart was not available at the time of reporting. At the time of this report, the patient had not recovered. Documents held by sender: None.
Tested positive for COVID; Tested positive for COVID; This is a spontaneous report received from a contactable Registered Nurse (patient) via a Pfizer sponsored program IBCC (Inbound Call Center for HCPs).  A female patient of an unspecified age received BNT162B2, via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced tested positive for COVID on an unspecified date with outcome of unknown. The patient just received the COVID vaccine, and also tested positive for COVID. The patient underwent lab tests and procedures which included COVID test: positive. Information on the lot/batch number has been requested.